Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 1,477-1,488 of 10,592
Behavioral study icon
RecruitingNCT05591937

S.T.A.N.D. Alacrity Center Signature Project

This study is looking at whether cognitive behavioural therapy can help people with Depression or Anxiety. Participants receive a study treatment and complete follow-up visits and assessments.

Remote / online
Anxiety, DepressionBehavioralFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Anxiety, Depression
Behavioral study icon
RecruitingNCT06640803

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

This study is looking at whether cognitive behavioural therapy can help people with Clinical High Risk for Psychosis or Ultra High Risk for Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

In United States
SchizophreniaBehavioralFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT04752618

Safe Mothers, Safe Children Initiative

This study is looking at whether P-STAIR can help people with Ptsd, Depression, or Child Maltreatment. Participants take part in P-STAIR and complete follow-up assessments.

In United States
PTSD, DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
New York University
Condition
PTSD, Depression
Behavioral study icon
RecruitingNCT06558409

Safer Still (Exploratory Project 3)

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityBehavioralFrom 18 Years to 90 Years
Countries
United States
Sponsor
Jeff Bridge
Condition
Suicidality
Behavioral study icon
RecruitingNCT05184335

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN64695913

Safety and efficacy study of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)

This study is looking at whether There is a 14-day screening period and a 3 to 7-day placebo washout period before randomisation of the participants for the trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
SchizophreniaOtherOver 18 Years
Countries
United States, Colombia, Germany, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Drug study icon
RecruitingNCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

This study is looking at care and outcomes for people with Schizophrenia or Bipolarity I. Taking part may give some people access to Iloperidone, but direct benefit is not guaranteed.

In United States
Schizophrenia, BipolarityDrugFrom 12 Years to 17 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.